ロード中...
Differential prescribing of antimuscarinic agents in older adults with cognitive impairment
BACKGROUND: Oral oxybutynin has been associated with the development of cognitive impairment. OBJECTIVE: The objective of this study was to describe the use of oral oxybutynin versus other antimuscarinics (e.g., tolterodine, darifenacin, solifenacin, trospium, fesoterodine, transdermal oxybutynin) i...
保存先:
| 出版年: | Drugs Aging |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5904003/ https://ncbi.nlm.nih.gov/pubmed/29492862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-018-0531-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|